Nebulized Magnesium Sulfate as an Adjunct to Standard Therapy in Asthma Exacerbation

• Status: Unknown status
• Trial end date: 2018-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate the effectiveness of nebulized magnesium sulfate in patient with moderate to severe asthma exacerbation in pediatric emergency

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hospital General Naval de Alta Especialidad - Escuela Medico Naval
• Treatments: Albuterol; Bromides; Ipratropium; Magnesium Sulfate; Methylprednisolone; Methylprednisolone acetate; Methylprednisolone Hemisuccinate; Prednisolone; Prednisolone acetate; Prednisolone hemisuccinate; Prednisolone phosphate

Criteria

Inclusion Criteria:

• Clinical diagnosis of moderate or severe asthma exacerbations

• 2 to 15 years old.

• Served in the pediatric emergency department of naval high specialty General Hospital from September to December 2015.

• Signing the consent by the parents.

Exclusion Criteria:

• Coexistence of lung disease.

• Severe kidney disease.

• Severe liver disease.

• Pregnancy.

• Known previous reaction to magnesium.

• Parents who have not signed the agreement.

• Patients without a clinical history of asthma.

• Clinical diagnosis of mild asthma attack.

• Previously included in the study.

• Presence of comorbidities that endanger the patient's life.

• The patient has clinical or gasometric criteria for advanced airway management.

• Life-threatening symptoms.